Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

S-Naproxen-β-1-O-acyl Glucuronide Degradation Kinetic Studies by Stopped-Flow High-Performance Liquid Chromatography-1H NMR and High-Performance Liquid Chromatography-UV

Rasmus W. Mortensen, Olivia Corcoran, Claus Cornett, Ulla G. Sidelmann, John C. Lindon, Jeremy K. Nicholson and Steen Honoré Hansen
Drug Metabolism and Disposition April 2001, 29 (4) 375-380;
Rasmus W. Mortensen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivia Corcoran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claus Cornett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulla G. Sidelmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John C. Lindon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy K. Nicholson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steen Honoré Hansen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Acyl-migrated isomers of drug β-1-O-acyl glucuronides have been implicated in drug toxicity because they can bind to proteins. The acyl migration and hydrolysis ofS-naproxen-β-1-O-acyl glucuronide (S-nap-g) was followed by dynamic stopped-flow HPLC-1H NMR and HPLC methods. Nine first order rate constants in the chemical equilibrium between six species (S-nap-g, its α/β-2-O-acyl, α/β-3-O-acyl, α/β-4-O-acyl, and α-1-O-acyl-migration isomers, andS-naproxen aglycone) were determined by HPLC-UV studies in 25 mM potassium phosphate buffer, pH 7.40, 25 mM potassium phosphate buffer in D2O pD 7.40, and 25 mM potassium phosphate buffer in D2O pD 7.40/MeCN 80:20 v/v (HPLC-1H NMR mobile phase). In the 25 mM potassium phosphate buffer (pH 7.40) the acyl-migration rate constants (h−1) were 0.18 (S-nap-g–α/β-2-O-acyl isomer), 0.23 (α/β-2-O-acyl–α-1-O-acyl), 2.6 (α-1-O-acyl–α/β-2-O-acyl), 0.12 (α/β-2-O-acyl–α/β-3-O-acyl), 0.048 (α/β-3-O-acyl–α/β-2-O-acyl), 0.059 (α/β-3-O-acyl–α/β-4-O-acyl), and 0.085 (α/β-4-O-acyl–α/β-3-O-acyl). The hydrolysis rate constants (h−1) were 0.025 (hydrolysis ofS-nap-g) and 0.0058 (hydrolysis of all acyl-migrated isomers). D2O and MeCN decreased the magnitude of all nine kinetic rate constants by up to 80%. The kinetic rate constants for the degradation of S-nap-g in the mobile phase used for HPLC-1H NMR determined using HPLC-UV could predict the results obtained by the dynamic stopped-flow HPLC-1H NMR experiments of the individual acyl-migrated isomers. It is therefore recommended that β-1-O-acyl glucuronide degradation kinetics be investigated by HPLC-UV methods once the identification and elution order of the isomers have been established by HPLC-1H NMR.

Footnotes

  • Send reprint requests to: Rasmus W. Mortensen, Pharmaceutical Stability Testing, Leo Pharmaceutical Products, 55, Industriparken, DK-2750 Ballerup, Denmark. E-mail:rasmus.mortensen{at}leo-pharma.com

  • ↵1 Current address: Pharmaceutical Stability Testing, Leo Pharmaceutical Products, 55, Industriparken, DK-2750 Ballerup, Denmark.

  • This work was supported by the European Union Biomed 2 program “Hyphenated Analytical Techniques”, Grant BMH4-CT97–2533 (DG 12-SSMI).

  • Abbreviations used are::
    S-nap-g
    S-naproxen-β-1-O-acyl glucuronide
    HPLC
    high-performance liquid chromatography
    pD
    minus the log10of the deuterium ion concentration
    • Received September 28, 2000.
    • Accepted December 14, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 29 (4)
Drug Metabolism and Disposition
Vol. 29, Issue 4
1 Apr 2001
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
S-Naproxen-β-1-O-acyl Glucuronide Degradation Kinetic Studies by Stopped-Flow High-Performance Liquid Chromatography-1H NMR and High-Performance Liquid Chromatography-UV
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

S-Naproxen-β-1-O-acyl Glucuronide Degradation Kinetic Studies by Stopped-Flow High-Performance Liquid Chromatography-1H NMR and High-Performance Liquid Chromatography-UV

Rasmus W. Mortensen, Olivia Corcoran, Claus Cornett, Ulla G. Sidelmann, John C. Lindon, Jeremy K. Nicholson and Steen Honoré Hansen
Drug Metabolism and Disposition April 1, 2001, 29 (4) 375-380;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

S-Naproxen-β-1-O-acyl Glucuronide Degradation Kinetic Studies by Stopped-Flow High-Performance Liquid Chromatography-1H NMR and High-Performance Liquid Chromatography-UV

Rasmus W. Mortensen, Olivia Corcoran, Claus Cornett, Ulla G. Sidelmann, John C. Lindon, Jeremy K. Nicholson and Steen Honoré Hansen
Drug Metabolism and Disposition April 1, 2001, 29 (4) 375-380;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Adipocyte PXR does not play an essential role in obesity.
  • CYP3A-mediated oxidation of DABE and BIBR0951
  • Biodistribution of Lipid in Rats
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics